Product Image

Omega-3 Fish Oil 1250 mg

SR Sports Research
4.8
★ ★ ★ ★ ★
(100652 ratings)
EPA (Eicosapentaenoic Acid) 690 mg
Omega-3 1040 mg
Fish Oil 1250 mg
DHA 260 mg
Product Image
Score84
A concentrated one-softgel fish oil with strong EPA content and value, offset by limited source and quality-control disclosure.
How scoring works
Quantity:90 Softgel(s) • (90 servings)
Goals:
Cardiovascular Support
Heart Health
Skin Health
Anti-Inflammatory Support
Joint Health

Score 84

A concentrated one-softgel fish oil with strong EPA content and value, offset by limited source and quality-control disclosure.
How scoring works
$27.97($0.31 per serving)
iHerb
$ 28.97
Vitacost
$ 27.97
iHerb
$ 28.97
Report prices

Analysis

One softgel supplies 1,040 mg total omega-3s, including 690 mg EPA and 260 mg DHA. The high active concentration is well aligned with heart, skin, and inflammatory goals, while the DHA amount is less suited to a DHA-first use.

EPA, DHA, other omega-3s, and total fish-oil concentrate are all quantified. The supplied information does not identify fish species, triglyceride or ethyl-ester form, antioxidant protection, independent testing, or inactive ingredients.

A 90-serving bottle combines convenience with strong active yield per serving. It is a good fit for adults who want a substantial dose without taking multiple softgels.

Who is it for
  • Adults seeking a one-softgel omega-3 routine
  • People focused on EPA-led cardiovascular support
Best for
  • High concentration per softgel
  • Convenient daily dosing

Pros

  • 1,040 mg total omega-3s in one softgel
  • 690 mg EPA is clearly disclosed
  • Strong active concentration

Cons

  • Molecular form is not stated
  • Fish species and purity testing are not disclosed
  • No antioxidant stabilizer appears in the supplied ingredients

Warnings

  • Avoid with a fish allergy
  • The EPA and DHA dose can add to anticoagulant or antiplatelet effects
  • Do not use softgels with a strong rancid odor because oxidation protection is not disclosed

Nutrient quality

89 Highest impact

High active concentration and substantial EPA plus DHA provide excellent dose quality. Missing form and oil-protection details limit confidence in absorption and freshness.

Ingredient transparency

81 Highest impact

Active fatty-acid quantities are clearly disclosed without a hidden blend. Missing full directions, excipients, and some oil-quality details reduce completeness.

Customer satisfaction

73 High impact

The supplied average rating is very strong and the rating volume is substantial. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

95 Highest impact

Formula quality and active-serving economics support strong practical value. It compares favorably within the category despite remaining disclosure gaps.

Report analysis

Goals

Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB+ CoverageA+ Formula Quality
Fish Oil · 1250 mg

EPA and DHA directly support triglyceride control, endothelial function, and inflammatory balance. The concentrated serving provides strong cardiovascular alignment.

Separate EPA, DHA, and total omega amounts are clearly disclosed at a substantial concentration. Fish oil may increase bruising or bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Fish Oil Supportive 185 studies
Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA+ Strength of SupportB- CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 690 mg

A concentrated EPA and DHA profile strongly supports triglyceride management and cardiovascular lipid biology. The substantial omega-3 amount is delivered in a focused single-softgel serving.

EPA, DHA, and other omega-3 fats are separately quantified, making potency easy to assess. Fish oil can increase bleeding tendency at higher intakes, so users taking anticoagulant or antiplatelet medicines should consider their total EPA and DHA exposure with a prescriber.

Study evidence
Skin Health
Skin Health
Impact
Highest effect
B Goal FitA+ Strength of SupportB CoverageA+ Formula Quality
Omega-3 · 90 mg

A concentrated EPA and DHA serving may support skin-barrier lipids and inflammatory balance, especially when dietary omega-3 intake is low. Human evidence for specific cosmetic skin outcomes is useful but less direct than evidence for hyaluronic acid or collagen.

The total omega-3, EPA, DHA, and other fatty-acid amounts are fully disclosed. Fish oil may increase bruising at high combined intakes with anticoagulant or antiplatelet medicines, and it is unsuitable for people with fish allergy.

Study evidence
Omega-3 Supportive 35 studies
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A+ Goal FitC+ Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 1250 mg

Concentrated EPA and DHA provide the most direct goal alignment in this group by supplying precursors for pro-resolving lipid mediators. The combined amount is close to a full gram in one softgel.

Individual fatty acids and total omega-3 content are clearly disclosed. Molecular form, fish species, purification, independent testing, and oxidation protection are not stated, so quality confidence trails the strong dose.

Study evidence
Fish Oil Supportive 68 studies
Joint Health
Joint Health
Impact
High effect
B+ Goal FitB+ Strength of SupportC CoverageA Formula Quality
Omega-3 · 90 mg

EPA and DHA provide meaningful support for inflammation-related joint comfort. The focused formula does not supply cartilage building blocks or joint lubrication.

The concentrated oil clearly discloses both major fatty acids. Fish oil may increase bleeding tendency when combined with anticoagulant or antiplatelet medicines.

Study evidence
Omega-3 Supportive 40 studies
Mental Focus
Mental Focus
Impact
Moderate effect
D+ Goal FitC+ Strength of SupportD CoverageA Formula Quality

EPA and DHA support brain-cell membranes and long-term neural health, but they are not strong acute focus enhancers. The formula is EPA-heavy, with a smaller DHA amount that is more directly relevant to brain structure.

All omega-3 amounts are transparent, while molecular form and contaminant testing are not disclosed. People with fish allergy should avoid the fish-oil source because it may trigger an allergic reaction.

Study evidence
Metabolism Boost
Metabolism Boost
Impact
Moderate effect
D+ Goal FitB- Strength of SupportD- CoverageA Formula Quality
Omega-3 · 90 mg

The concentrated fish oil provides substantial EPA and DHA, which may support insulin sensitivity and lipid metabolism. Its metabolic role is supportive rather than a direct increase in thermogenesis or mitochondrial energy output.

The active fatty acids are clearly separated and delivered in a lean one-softgel formula. The unconfirmed molecular form and lack of stated purity testing leave some uncertainty about absorption and quality.

Study evidence
Omega-3 Supportive 42 studies

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Fish Oil Concentrate
1250 mg
Total Omega-3 Fatty Acids
1040 mg
Eicosapentaenoic Acid
690 mg
Docosahexaenoic Acid
260 mg
Other Omega-3 Fatty Acids
90 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
EPA (Eicosapentaenoic Acid) · 690 mg OverallScore67
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The formula delivers a substantial EPA dose with much more EPA than DHA, making it well aligned with an EPA-focused use. EPA is concentrated within the fish oil and offers strong cost efficiency. However, the label does not state the molecular form, antioxidant protection, purification method, or independent contaminant testing.

View ingredientView products
Omega-3 · 1040 mg OverallScore66
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The concentrated oil delivers a high proportion of EPA and DHA in one softgel, with both fatty acids listed separately. Its molecular form is not explicitly confirmed and the generic fish source lacks stated antioxidant protection. Strong active delivery at a low cost per gram supports value, though no independent purity verification is provided.

View ingredientView products
Fish Oil · 1250 mg OverallScore53
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyA+ Value

The serving provides 950 mg of EPA and DHA in a highly concentrated oil. Individual fatty acids are clearly disclosed, but the molecular form, purification method, independent testing, and antioxidant protection are not stated. The active omega-3 amount is delivered at excellent value despite those quality-documentation gaps.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
<p>Its ingredient profile and goal alignment make it a stronger formulation-focused alternative. Triglyceride fish oil delivers a highly concentrated EPA-led omega-3 serving with clear fatty-acid amounts and especially favorable package value. Molecular distillation adds some purity assurance, while missing independent testing, fish species, and antioxidant protection leave smaller quality gaps.</p>
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
<p>Its ingredient profile and goal alignment make it a stronger formulation-focused alternative. A substantial, clearly separated EPA and DHA serving offers strong potency and active value. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent purity testing are not supplied.</p>
85 Performance

Wild Alaskan Fish Oil Peak EPA

Wiley's Finest
<p>Its ingredient profile and goal alignment make it a stronger formulation-focused alternative. A concentrated EPA-heavy serving provides meaningful omega-fat support with clear individual fatty-acid amounts. Unspecified molecular form, oxidation protection, purification, and independent testing limit quality assurance despite favorable active value.</p>
84 Budget

Fish Oil 1400 mg

Nature's Bounty
<p>The lower serving cost makes this a more economical alternative. A meaningful EPA-led amount and strong oil concentration provide good active value. The ethyl-ester form is less readily absorbed, while fish source, antioxidant protection, and independent purity testing are not stated.</p>
84 Budget

Omega 3 Fish Oil Concentrate

Solgar
<p>The lower serving cost makes this a more economical alternative. The triglyceride form supports absorption and the individual fatty acids are clearly disclosed. Active concentration is modest, but low serving cost creates attractive value despite missing source, oxidation, and purity details.</p>
82 Budget

Triple Strength Omega-3

InnovixLabs
<p>The lower serving cost makes this a more economical alternative. A concentrated blend of EPA, DHA, DPA, and other omega-3s offers a useful maintenance amount at excellent value. Missing molecular-form, purification, species, antioxidant, and independent-testing details weaken quality assurance, while one malformed label row reduces clarity.</p>
79 Value

Fish Oil 1000 mg

Mason Natural
<p>The balance of ingredient quality and serving economy makes it a stronger value choice. Individual EPA and DHA amounts are clear, and the very inexpensive softgel may cover basic intake. The serving is low in active omega fats, while source, molecular form, oxidation protection, and purity testing are absent.</p>
82 Value

Omega 3 Fish Oil Concentrate

Solgar
<p>The balance of ingredient quality and serving economy makes it a stronger value choice. The modest EPA and DHA serving is clearly disclosed and inexpensive for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details prevent a stronger quality conclusion.</p>
69 Value

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
<p>The balance of ingredient quality and serving economy makes it a stronger value choice. Triglyceride fish oil and vitamin E suit a child-friendly chewable, but the active omega-3 amount and oil concentration are low. A long supply and extensive rating volume help usability, while missing purity testing and malformed label entries reduce clarity.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  5. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  7. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  8. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
    Furuhjelm C; Warstedt K; Fagerås M; Fälth-Magnusson K; Larsson J; Fredriksson M; Duchén K · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2011
    Randomized trial145 participantsSkin Health forOmega-3
  9. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study.
    Søyland E; Funk J; Rajka G; Sandberg M; Thune P; Rustad L; Helland S; Middelfart K; Odu S; Falk ES · The British journal of dermatology · 1994
    Randomized trial145 participantsSkin Health forOmega-3
  10. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  11. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  12. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  13. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  14. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  15. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  16. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  17. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  18. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  19. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  20. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  21. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  22. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  23. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  24. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  25. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  26. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  27. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  28. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  29. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  30. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  31. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  32. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  33. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  34. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  35. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  36. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  37. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  38. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  39. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3